S&P 500   4,997.81 (-0.27%)
DOW   38,091.03 (+0.84%)
QQQ   417.03 (-1.51%)
AAPL   165.21 (-1.10%)
MSFT   401.21 (-0.76%)
META   486.91 (-2.97%)
GOOGL   154.59 (-0.91%)
AMZN   175.51 (-2.07%)
TSLA   148.94 (-0.66%)
NVDA   804.39 (-5.00%)
AMD   149.63 (-3.51%)
NIO   3.84 (-4.00%)
BABA   68.98 (+0.15%)
T   16.42 (+0.55%)
F   12.14 (+0.66%)
MU   107.35 (-4.09%)
GE   149.95 (-1.96%)
CGC   8.16 (+4.21%)
DIS   112.41 (-0.02%)
AMC   3.25 (+11.30%)
PFE   25.85 (+1.81%)
PYPL   62.32 (+0.35%)
XOM   120.12 (+1.35%)
S&P 500   4,997.81 (-0.27%)
DOW   38,091.03 (+0.84%)
QQQ   417.03 (-1.51%)
AAPL   165.21 (-1.10%)
MSFT   401.21 (-0.76%)
META   486.91 (-2.97%)
GOOGL   154.59 (-0.91%)
AMZN   175.51 (-2.07%)
TSLA   148.94 (-0.66%)
NVDA   804.39 (-5.00%)
AMD   149.63 (-3.51%)
NIO   3.84 (-4.00%)
BABA   68.98 (+0.15%)
T   16.42 (+0.55%)
F   12.14 (+0.66%)
MU   107.35 (-4.09%)
GE   149.95 (-1.96%)
CGC   8.16 (+4.21%)
DIS   112.41 (-0.02%)
AMC   3.25 (+11.30%)
PFE   25.85 (+1.81%)
PYPL   62.32 (+0.35%)
XOM   120.12 (+1.35%)
S&P 500   4,997.81 (-0.27%)
DOW   38,091.03 (+0.84%)
QQQ   417.03 (-1.51%)
AAPL   165.21 (-1.10%)
MSFT   401.21 (-0.76%)
META   486.91 (-2.97%)
GOOGL   154.59 (-0.91%)
AMZN   175.51 (-2.07%)
TSLA   148.94 (-0.66%)
NVDA   804.39 (-5.00%)
AMD   149.63 (-3.51%)
NIO   3.84 (-4.00%)
BABA   68.98 (+0.15%)
T   16.42 (+0.55%)
F   12.14 (+0.66%)
MU   107.35 (-4.09%)
GE   149.95 (-1.96%)
CGC   8.16 (+4.21%)
DIS   112.41 (-0.02%)
AMC   3.25 (+11.30%)
PFE   25.85 (+1.81%)
PYPL   62.32 (+0.35%)
XOM   120.12 (+1.35%)
S&P 500   4,997.81 (-0.27%)
DOW   38,091.03 (+0.84%)
QQQ   417.03 (-1.51%)
AAPL   165.21 (-1.10%)
MSFT   401.21 (-0.76%)
META   486.91 (-2.97%)
GOOGL   154.59 (-0.91%)
AMZN   175.51 (-2.07%)
TSLA   148.94 (-0.66%)
NVDA   804.39 (-5.00%)
AMD   149.63 (-3.51%)
NIO   3.84 (-4.00%)
BABA   68.98 (+0.15%)
T   16.42 (+0.55%)
F   12.14 (+0.66%)
MU   107.35 (-4.09%)
GE   149.95 (-1.96%)
CGC   8.16 (+4.21%)
DIS   112.41 (-0.02%)
AMC   3.25 (+11.30%)
PFE   25.85 (+1.81%)
PYPL   62.32 (+0.35%)
XOM   120.12 (+1.35%)

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AINC
Ashford
$4.81
-0.4%
$0.00
$1.91
$11.90
$16.50M1.64294,435 shs15,489 shs
ATIF Holdings Limited stock logo
ATIF
ATIF
$0.94
-4.1%
$0.97
$0.65
$2.00
$9.05M-0.4715,911 shs6,575 shs
Gopher Protocol Inc stock logo
GOPH
Gopher Protocol
$0.00
$0.05
$1.63
$10.82M3.22883,328 shs58.84 million shs
Lightbridge Co. stock logo
LTBR
Lightbridge
$2.52
+0.8%
$2.87
$2.45
$6.70
$35.76M2.5575,708 shs23,810 shs
Pharma-Bio Serv, Inc. stock logo
PBSV
Pharma-Bio Serv
$0.80
+6.7%
$0.87
$0.65
$1.10
$18.37M0.511,415 shs7,000 shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AINC
Ashford
+0.42%+2.33%+482,999,900.00%+482,999,900.00%+482,999,900.00%
ATIF Holdings Limited stock logo
ATIF
ATIF
0.00%0.00%-4.85%-11.71%-45.86%
Gopher Protocol Inc stock logo
GOPH
Gopher Protocol
0.00%0.00%0.00%0.00%-71.43%
Lightbridge Co. stock logo
LTBR
Lightbridge
-0.79%-10.71%-17.22%-18.30%-36.39%
Pharma-Bio Serv, Inc. stock logo
PBSV
Pharma-Bio Serv
+6.67%-6.76%+0.76%-23.81%-20.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AINC
Ashford
N/AN/AN/AN/AN/AN/AN/AN/A
ATIF Holdings Limited stock logo
ATIF
ATIF
N/AN/AN/AN/AN/AN/AN/AN/A
Gopher Protocol Inc stock logo
GOPH
Gopher Protocol
N/AN/AN/AN/AN/AN/AN/AN/A
Lightbridge Co. stock logo
LTBR
Lightbridge
N/AN/AN/AN/AN/AN/AN/AN/A
Pharma-Bio Serv, Inc. stock logo
PBSV
Pharma-Bio Serv
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AINC
Ashford
N/AN/AN/AN/A
ATIF Holdings Limited stock logo
ATIF
ATIF
N/AN/AN/AN/A
Gopher Protocol Inc stock logo
GOPH
Gopher Protocol
N/AN/AN/AN/A
Lightbridge Co. stock logo
LTBR
Lightbridge
N/AN/AN/AN/A
Pharma-Bio Serv, Inc. stock logo
PBSV
Pharma-Bio Serv
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AINC
Ashford
$765.86M0.02$24.05 per share0.20($94.76) per share-0.05
ATIF Holdings Limited stock logo
ATIF
ATIF
$2.45M3.69N/AN/A$0.16 per share5.88
Gopher Protocol Inc stock logo
GOPH
Gopher Protocol
$51.57M0.00N/AN/A$0.08 per share0.00
Lightbridge Co. stock logo
LTBR
Lightbridge
N/AN/AN/AN/A$2.23 per shareN/A
Pharma-Bio Serv, Inc. stock logo
PBSV
Pharma-Bio Serv
$16.98M1.08$0.07 per share11.46$0.70 per share1.14

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AINC
Ashford
-$4.63M-$13.38N/AN/A-0.60%-17.01%10.18%5/8/2024 (Estimated)
ATIF Holdings Limited stock logo
ATIF
ATIF
-$2.88M-$0.47N/AN/A-1,153.75%-238.36%-105.66%6/12/2024 (Estimated)
Gopher Protocol Inc stock logo
GOPH
Gopher Protocol
-$51.77MN/A0.00N/AN/A-80.22%-284.85%-136.31%N/A
Lightbridge Co. stock logo
LTBR
Lightbridge
-$7.91M-$0.64N/AN/AN/A-27.51%-26.92%5/8/2024 (Estimated)
Pharma-Bio Serv, Inc. stock logo
PBSV
Pharma-Bio Serv
$1.31M$0.0326.687.27N/A4.05%3.95%3.10%6/12/2024 (Estimated)

Latest ATIF, GOPH, LTBR, AINC, and PBSV Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/18/2024Q2 2024
ATIF Holdings Limited stock logo
ATIF
ATIF
N/A-$0.04-$0.04-$0.04N/A$0.03 million
3/18/2024Q1 2024
Pharma-Bio Serv, Inc. stock logo
PBSV
Pharma-Bio Serv
$0.02-$0.01-$0.03-$0.01$5.00 million$2.38 million
2/29/2024Q4 2023
AINC
Ashford
N/A$0.98+$0.98$6.32$187.90 million$206.81 million
2/28/2024Q4 2023
Lightbridge Co. stock logo
LTBR
Lightbridge
N/A-$0.18-$0.18-$0.18N/AN/A
1/29/2024Q4 2023
Pharma-Bio Serv, Inc. stock logo
PBSV
Pharma-Bio Serv
$0.03$0.03N/AN/A$5.00 million$3.60 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AINC
Ashford
N/AN/AN/AN/AN/A
ATIF Holdings Limited stock logo
ATIF
ATIF
N/AN/AN/AN/AN/A
Gopher Protocol Inc stock logo
GOPH
Gopher Protocol
N/AN/AN/AN/AN/A
Lightbridge Co. stock logo
LTBR
Lightbridge
N/AN/AN/AN/AN/A
Pharma-Bio Serv, Inc. stock logo
PBSV
Pharma-Bio Serv
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AINC
Ashford
N/A
1.04
1.02
ATIF Holdings Limited stock logo
ATIF
ATIF
N/A
1.11
1.11
Gopher Protocol Inc stock logo
GOPH
Gopher Protocol
N/A
0.39
0.39
Lightbridge Co. stock logo
LTBR
Lightbridge
N/A
59.27
59.27
Pharma-Bio Serv, Inc. stock logo
PBSV
Pharma-Bio Serv
N/A
5.10
5.10

Ownership

Institutional Ownership

CompanyInstitutional Ownership
AINC
Ashford
13.32%
ATIF Holdings Limited stock logo
ATIF
ATIF
N/A
Gopher Protocol Inc stock logo
GOPH
Gopher Protocol
N/A
Lightbridge Co. stock logo
LTBR
Lightbridge
9.14%
Pharma-Bio Serv, Inc. stock logo
PBSV
Pharma-Bio Serv
N/A

Insider Ownership

CompanyInsider Ownership
AINC
Ashford
66.70%
ATIF Holdings Limited stock logo
ATIF
ATIF
55.20%
Gopher Protocol Inc stock logo
GOPH
Gopher Protocol
N/A
Lightbridge Co. stock logo
LTBR
Lightbridge
6.50%
Pharma-Bio Serv, Inc. stock logo
PBSV
Pharma-Bio Serv
12.00%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
AINC
Ashford
N/A3.43 million1.14 millionN/A
ATIF Holdings Limited stock logo
ATIF
ATIF
139.63 million4.31 millionNot Optionable
Gopher Protocol Inc stock logo
GOPH
Gopher Protocol
26220.87 millionN/ANot Optionable
Lightbridge Co. stock logo
LTBR
Lightbridge
614.19 million13.27 millionOptionable
Pharma-Bio Serv, Inc. stock logo
PBSV
Pharma-Bio Serv
10022.96 million20.21 millionNot Optionable

ATIF, GOPH, LTBR, AINC, and PBSV Headlines

SourceHeadline
Pharma-Bio Serv (OTCMKTS:PBSV) Shares Cross Below Two Hundred Day Moving Average of $0.92Pharma-Bio Serv (OTCMKTS:PBSV) Shares Cross Below Two Hundred Day Moving Average of $0.92
americanbankingnews.com - April 18 at 3:44 AM
Buy Rating Affirmed for BioMarin Pharmaceutical Amidst Strong Sales Outlook and Optimized Market ExpectationsBuy Rating Affirmed for BioMarin Pharmaceutical Amidst Strong Sales Outlook and Optimized Market Expectations
markets.businessinsider.com - April 16 at 3:38 AM
Pharma-Bio Serv (OTCMKTS:PBSV) Stock Crosses Above 50 Day Moving Average of $0.89Pharma-Bio Serv (OTCMKTS:PBSV) Stock Crosses Above 50 Day Moving Average of $0.89
americanbankingnews.com - April 10 at 4:32 AM
Sanguine Biosciences Affirms Superior Quality of its Biospecimen Services Using VERIF.i®, Scientist.coms Supplier Pre-assessment ProgramSanguine Biosciences Affirms Superior Quality of its Biospecimen Services Using VERIF.i®, Scientist.com's Supplier Pre-assessment Program
tmcnet.com - April 9 at 8:56 AM
Looking Into Biomarin Pharmaceuticals Recent Short InterestLooking Into Biomarin Pharmaceutical's Recent Short Interest
benzinga.com - April 3 at 3:20 PM
PBSV Releases Quarterly ResultsPBSV Releases Quarterly Results
finance.yahoo.com - March 19 at 3:02 PM
Pharma-Bio Serv reports Q1 resultsPharma-Bio Serv reports Q1 results
seekingalpha.com - March 19 at 10:01 AM
Pharma-Bio Serv Announces Results for the Quarter…Pharma-Bio Serv Announces Results for the Quarter…
pharmiweb.com - March 19 at 12:00 AM
Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2024Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2024
accesswire.com - March 18 at 5:10 PM
Buy Rating Affirmed for BridgeBio Pharma Amidst Strategic Bayer Collaboration and Promising Financial OutlookBuy Rating Affirmed for BridgeBio Pharma Amidst Strategic Bayer Collaboration and Promising Financial Outlook
markets.businessinsider.com - March 4 at 11:00 PM
Maintaining Hold on BridgeBio Pharma Amidst Bayer Partnership and Market UncertaintiesMaintaining Hold on BridgeBio Pharma Amidst Bayer Partnership and Market Uncertainties
markets.businessinsider.com - March 4 at 12:58 PM
BioMarin Pharmaceutical Gets DOJ Subpoena for Documents Related to Vimizim, Naglazyme -- UpdateBioMarin Pharmaceutical Gets DOJ Subpoena for Documents Related to Vimizim, Naglazyme -- Update
marketwatch.com - February 26 at 4:21 PM
Strong Voxzogo Performance Underpins Buy Rating for BioMarin PharmaceuticalStrong Voxzogo Performance Underpins Buy Rating for BioMarin Pharmaceutical
markets.businessinsider.com - February 23 at 8:53 PM
Pharma-Bio Serv reports revenue of $17M for 2023Pharma-Bio Serv reports revenue of $17M for 2023
newsismybusiness.com - January 31 at 7:39 AM
Regeneron Acquires 2seventy Bio Platforms and Preclinical & Clinical ProgramsRegeneron Acquires 2seventy Bio Platforms and Preclinical & Clinical Programs
contractpharma.com - January 30 at 4:38 PM
PBSV Expands Margins and MarketsPBSV Expands Margins and Markets
finance.yahoo.com - January 30 at 4:38 PM
Jubilant Pharma Plans Stake Sale in Sofie Biosciences Amid Merger DealJubilant Pharma Plans Stake Sale in Sofie Biosciences Amid Merger Deal
msn.com - January 28 at 10:10 AM
BridgeBio Pharma inks $1.25bnBridgeBio Pharma inks $1.25bn
pehub.com - January 23 at 12:11 PM
Optimistic Outlook: Buy Rating for BridgeBio Pharma with Promising Treatment Launches and Strategic Growth DriversOptimistic Outlook: Buy Rating for BridgeBio Pharma with Promising Treatment Launches and Strategic Growth Drivers
markets.businessinsider.com - January 9 at 8:52 PM
BridgeBio Pharmas Robust Pipeline Could Benefit From A PartnerBridgeBio Pharma's Robust Pipeline Could Benefit From A Partner
seekingalpha.com - January 8 at 8:02 AM
PBSV Reward Shareholders with High YieldPBSV Reward Shareholders with High Yield
finance.yahoo.com - January 3 at 3:22 PM
Pharma-Bio Serv Inc.: Pharma-Bio Serv Announces Special DividendPharma-Bio Serv Inc.: Pharma-Bio Serv Announces Special Dividend
finanznachrichten.de - December 21 at 1:54 PM
AbbVies on an Acquisition Binge. Could Your Favorite Biotech Stock Be Next?AbbVie's on an Acquisition Binge. Could Your Favorite Biotech Stock Be Next?
msn.com - December 8 at 8:18 AM
BioMarin Pharma Reaches Agreement On Reimbursement Amount For ROCTAVIAN In GermanyBioMarin Pharma Reaches Agreement On Reimbursement Amount For ROCTAVIAN In Germany
markets.businessinsider.com - November 28 at 9:18 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Ashford

NYSE:AINC
Ashford, Inc is an asset management firm. The firm provides investment management and related services to the real estate and hospitality sectors. Ashford, Inc was formed on April 2, 2014 and is based in Dallas, Texas. Ashford Inc.(NYSEAM:AINC) operates independently of Ashford Hospitality Trust, Inc. as of November 5, 2019.
ATIF logo

ATIF

NASDAQ:ATIF
ATIF Holdings Limited operates as a business consulting company in Hong Kong, the United States, and Mexico. It offers financial consulting services to small and medium-sized enterprises (SMEs). The company primarily focuses on helping clients going public on the national stock exchanges and OTC markets in the United States. Its consulting services primarily include due diligence review, market research and feasibility study, business plan drafting, accounting record review, and business analysis and recommendations; reorganization, pre-listing education and tutoring, talent search, legal and audit firm recommendation and coordination, VIE contracts and other public-listing related documents review, merger and acquisition planning, investor referral and pre-listing equity financing source identification and recommendations, and independent directors and audit committee candidate's recommendation. The company also offers shell company identification and recommendation for customers expecting to become publicly listed through reverse merger transaction; assistance in preparation of customers' public filings for IPO or reverse merger transactions; and assistance in answering comments and questions received from regulatory agencies. In addition, it operates chinacnnm.com, a news and media website focuses on distributing financial news and information. ATIF Holdings Limited was incorporated in 2015 and is based in Lake Forest, California.
Gopher Protocol logo

Gopher Protocol

OTCMKTS:GOPH
Gopher Protocol Inc., a development-stage company, engages in developing Internet of Things and artificial intelligence enabled mobile technology. Its technology consists of a smart microchip, mobile application software, and supporting software. The company also sells phones and phone card products, including PINS, SIM cards, and gift cards. The company was formerly known as Forex International Trading Corp. and changed its name to Gopher Protocol Inc. in February 2015. Gopher Protocol Inc. was founded in 2009 and is headquartered in Santa Monica, California.
Lightbridge logo

Lightbridge

NASDAQ:LTBR
Lightbridge Corporation, together with its subsidiaries, engages in developing nuclear fuel technology. It develops and commercializes metallic nuclear fuels. The company was formerly known as Thorium Power, Ltd. and changed its name to Lightbridge Corporation in September 2009. Lightbridge Corporation is headquartered in Reston, Virginia.
Pharma-Bio Serv logo

Pharma-Bio Serv

OTCMKTS:PBSV
Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. Pharma-Bio Serv, Inc. was founded in 1993 and is headquartered in Dorado, Puerto Rico.